J. Goldman & Co »

Catalyst Pharmaceutical Partners shares owned by J. Goldman & Co

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by J. Goldman & Co from 13F filings

Historical chart of J. Goldman & Co investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by J. Goldman & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by J. Goldman & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $450k 27k 16.81
2023-09-30 $158k 14k 11.69
2023-06-30 $7.1M 527k 13.44
2023-03-31 $1.8M 111k 16.58
2020-06-30 $499k 108k 4.62
2020-03-31 $1.8M 455k 3.85

More positions owned by J. Goldman & Co

Paypal Holdings (PYPL)
Advisorshares Tr Pure Us Cannabis (MSOS)
Microsoft Corporation (MSFT)
Lowe's Companies (LOW)
Spotify Technology S A SHS (SPOT)
Tko Group Holdings Cl A (TKO)
Regeneron Pharmaceuticals (REGN)
Select Sector Spdr Tr Technology (XLK)
Norfolk Southern (NSC)
Dollar Tree (DLTR)
Rivian Automotive Com Cl A (RIVN)
Eli Lilly & Co. (LLY)
Canadian Pacific Kansas City (CP)
Hasbro (HAS)
MDU Resources (MDU)

View all positions for J. Goldman & Co

Top funds holding Catalyst Pharmaceutical Partners

Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Royce & Associates
Robeco Investment Management
Jacobs Levy Equity Management
Opaleye Management
LSV Asset Management
T. Rowe Price Associates
Henderson Group
Goldman Sachs Group
Charles Schwab Investment Management
Jupiter Asset Management
Bank of New York Mellon
Bank of America Corporation

View all funds holding Catalyst Pharmaceutical Partners